Clinical Trial Update: TILs Therapy for Multiple Primary Early-Stage NSCLC [EARLY_Phase 1]

View source ↗

Summary

Trial update for TILs therapy targeting multiple primary early-stage non-small cell lung cancer, currently in early phase 1 and not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• TILs therapy (tumor-infiltrating lymphocytes)

Snippet

Sponsor: Tianjin Medical University General Hospital | Conditions: Primary Early-stage Non-small Cell Lung Cancer | EARLY_Phase 1 | Status: NOT_YET_RECRUITING